VERTEX PHARMACEUTICALS INC / MA (VRTX)
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
The Kraft Heinz Company Declares Regular Quarterly Dividend of $0.40 Per Share
Immunocore reports first quarter financial results and provides a business update
Insulet - Insulet Reports First Quarter 2026 Results
908 Devices Inc. - 908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
Sprott Announces First Quarter 2026 Results
Strata Critical Medical Announces First Quarter 2026 Results
CDW Reports First Quarter 2026 Earnings